Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma

Chiosea, SI and Grandis, JR and Lui, VWY and Diergaarde, B and Maxwell, JH and Ferris, RL and Kim, SW and Luvison, A and Miller, M and Nikiforova, MN (2013) PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma. BMC Cancer, 13.

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (425kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

Background: Recent genomic evidence suggests frequent phosphatidylinositide 3-kinase (PI3K) pathway activation in human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma. Mutations/amplification of the gene encoding p110α catalytic subunit of phosphoinositide 3-kinase (PIK3CA), loss of phosphatase and tensin homolog (PTEN) and HRAS mutations are known to activate PI3K pathway. Methods and results: PIK3CA mutations were identified by Sanger sequencing in 23 of 75 (31%) HPV-positive oropharyngeal carcinomas, including exon 9 (p.E545K [n = 10] and p.E542K [n = 5]) or exon 20 (p.H1047Y, n = 2) mutations. Five rare and one novel (p.R537Q) PIK3CA mutations were identified. HRAS mutation (p.Q61L) was detected in 1 of 62 tested cases. PIK3CA amplification by fluorescence in situ hybridization (FISH) was identified in 4 cases (4/21, 20%), while PTEN loss was seen in 7 (7/21, 33%) cases (chromosome 10 monosomy [n = 4], homozygous deletion [n = 3]). Conclusions: Overall, genetic alterations that likely lead to PI3K pathway activation were identified in 34 of 75 cases (45%) and did not correlate with disease specific survival. These findings offer a molecular rationale for therapeutic targeting of PI3K pathway in patients with HPV-positive oropharyngeal carcinoma. © 2013 Chiosea et al.; licensee BioMed Central Ltd.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Chiosea, SIsic5@pitt.eduSIC5
Grandis, JRjgrandis@pitt.eduJGRANDIS
Lui, VWY
Diergaarde, Bbbd3@pitt.eduBBD3
Maxwell, JH
Ferris, RLrlf1@pitt.eduRLF1
Kim, SWswk7@pitt.eduSWK7
Luvison, A
Miller, M
Nikiforova, MNmnn4@pitt.eduMNN4
Date: 17 December 2013
Date Type: Publication
Journal or Publication Title: BMC Cancer
Volume: 13
DOI or Unique Handle: 10.1186/1471-2407-13-602
Schools and Programs: School of Medicine > Otolaryngology
School of Medicine > Pathology
Refereed: Yes
Date Deposited: 02 Dec 2016 18:30
Last Modified: 02 Feb 2019 16:58
URI: http://d-scholarship.pitt.edu/id/eprint/29633

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item